Anhedonia is an important factor of health-related quality-of-life deficit in schizophrenia and schizoaffective disorder

Journal of Nervous and Mental Disease

Volumn 199, Issue 11, 2011, Pages 845-853

  Ritsner, Michael S ^a,b   Arbitman, Marina ^a,b   Lisker, Alexander ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b SHA'AR MENASHE MENTAL HEALTH CENTER   (Israel)

Author keywords

anhedonia; Quality of life; schizoaffective disorder; schizophrenia

Indexed keywords

ADULT; AGED; ANHEDONIA; ARTICLE; COPING BEHAVIOR; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; QUALITY OF LIFE; QUALITY OF LIFE ENJOYMENT AND LIFE SATISFACTION QUESTIONNAIRE; QUESTIONNAIRE; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SELF CONCEPT; SOCIAL ANHEDONIA SCALE; SOCIAL SUPPORT; SYMPTOM;

ADULT; AGED; ANHEDONIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOLOGICAL TESTS; PSYCHOTIC DISORDERS; QUALITY OF LIFE; REGRESSION ANALYSIS; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL;

EID: 80455178733     PISSN: 00223018     EISSN: 1539736X     Source Type: Journal    
DOI: 10.1097/NMD.0b013e3182349ce6     Document Type: Article

References (89)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th ed).Washington, DC: American Psychiatric Association.
2. Assouly-Besse FS, Dollfus S, Petit M (1995) French translation of the Chapman Social and Physical Anhedonia Questionnaire: Validation of the French translation in controls and schizophrenic patients [in French]. Encephale. 21: 273-284.
3. Basco MR, Krebaum SR, Rush AJ (1997) Outcome measures of depression. In Strupp HH, Horowitz LM, Lambert MJ (Eds), Measuring patient changes in mood, anxiety, and personality disorders: Toward a core battery (pp 191-245). Washington, DC: American Psychological Association.
4. Bechdolf A, Klosterkotter J, Hambrecht M, Knost B, Kuntermann C, Schiller S, Pukrop R (2003) Determinants of subjective quality of life in post acute patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. 253:228-235. (Pubitemid 37203959)
5. Berridge KC, Kringelbach ML (2008) Affective neuroscience of pleasure: Reward in humans and animals. Psychopharmacology (Berl). 199:457-480.
6. Blanchard JJ, Bellack AS, Mueser KT (1994) Affective and social-behavioral correlates of physical and social anhedonia in schizophrenia. J Abnorm Psychol. 103:719-728. (Pubitemid 24349354)
7. Blanchard JJ, Horan WP, Brown SA (2001) Diagnostic differences in social anhedonia: A longitudinal study of schizophrenia and major depressive disorder. J Abnorm Psychol. 110:363-371. (Pubitemid 32703074)
8. Burbridge JA, Barch DM (2007) Anhedonia and the experience of emotion in individuals with schizophrenia. J Abnorm Psychol. 116:30-42. (Pubitemid 46328613)
9. Chan RC, Wang Y, Huang J, Shi Y, Wang Y, Hong X, Ma Z, Li Z, Lai MK, Kring AM (2010) Anticipatory and consummatory components of the experience of pleasure in schizophrenia: Cross-cultural validation and extension. Psychiatry Res. 175:181-183.
10. Chapman LJ, Chapman JP, Kwapil TR, Eckblad M, Zinser MC (1994) Putatively psychosis-prone subjects 10 years later. J Abnorm Psychol. 103:171-183. (Pubitemid 24152791)
11. Chapman LJ, Chapman JP, Raulin ML (1976) Scales for physical and social anhedonia. J Abnorm Psychol. 85:374-382.
12. Cohen AS, Minor KS (2010) Emotional experience in patients with schizophrenia revisited: Meta-analysis of laboratory studies. Schizophr Bull. 36:143-150.
13. Crespo-Facorro B, Paradiso S, Andreasen NC, O'Leary DS,Watkins GL, Ponto LL, Hichwa RD (2001) Neural mechanisms of anhedonia in schizophrenia: A PET study of response to unpleasant and pleasant odors. JAMA. 286:427-435. (Pubitemid 32681485)
14. Davidson RJ (2004) Well-being and affective style: Neural substrates and biobehavioural correlates. Philos Trans R Soc Lond B Biol Sci. 359:1395-1411. (Pubitemid 39275378)
15. Derogatis LR, Spencer PM (1982) The Brief Symptom Inventory (BSI): Administration, Scoring and Procedures Manual. Baltimore,MD: Johns Hopkins University, School of Medicine.
16. Dowd EC, Barch DM (2010) Anhedonia and emotional experience in schizophrenia: Neural and behavioral indicators. Biol Psychiatry. 67:902-911.
17. Eklund M, Backstrom M, Hansson L (2003) Personality and self-variables: Important determinants of subjective quality of life in schizophrenia out-patients. Acta Psychiatr Scand. 108:134-143. (Pubitemid 36801806)
18. Endicott J, Nee J, Harrison W, Blumenthal R (1993) Quality of life enjoyment and satisfaction questionnaire: A new measure. Psychopharmacol Bull. 29: 321-326. (Pubitemid 23311543)
19. Endler NS, Parker JD (1990) Multidimensional assessment of coping: A critical evaluation. J Pers Soc Psychol. 58:844-854.
20. Fitzgerald PB, Williams CL, Corteling N (2001) Subject and observer-rated quality of life in schizophrenia. Acta Psychiatr Scand. 103:387-392. (Pubitemid 32436752)
21. Fonseca-Pedrero E, Paino M, Lemos-Giráldez S, Garc?́a-Cueto E, Villazón-Garc?́a U, Bobes J, Muñiz J (2009) Psychometric properties of the Revised Physical and Social Anhedonia Scales in non-clinical young adults. Span J Psychol. 12:815-822.
22. Gard DE, Kring AM, Gard MG, Horan WP, Green MF (2007) Anhedonia in schizophrenia: Distinctions between anticipatory and consummatory pleasure. Schizophr Res. 93:253-260. (Pubitemid 46817952)
23. Germans MK, Kring AM (2000) Hedonic deficit in anhedonia: Support for the role of approach motivation. Pers Individ Differ. 28:659-672.
24. Gorwood P (2008) Neurobiological mechanisms of anhedonia. Dialogues Clin Neurosci. 10:291-299.
25. Guy W (1976) ECDU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Health and Human Services
26. Hansson L, Middelboe T, Merinder L, Bjarnason O, Bengtsson-Tops A, Nilsson L, Sandlund M, Sourander A, Sorgaard KW, Vinding H (1999) Predictors of subjective quality of life in schizophrenic patients living in the community. A Nordic multicentre study Int J Soc Psychiatry. 45:247-258. (Pubitemid 30072593)
27. Harvey PO, Bodnar M, Sergerie K, Armony J, Lepage M (2009) Relation between emotional face memory and social anhedonia in schizophrenia. J Psychiatry Neurosci. 34:102-110.
28. Harvey PO, Armony J, Malla A, Lepage M (2010) Functional neural substrates of self-reported physical anhedonia in non-clinical individuals and in patients with schizophrenia. J Psychiatr Res. 44:707-716.
29. Herbener ES, Harrow M (2002) The course of anhedonia during 10 years of schizophrenic illness. J Abnorm Psychol. 111:237-248. (Pubitemid 34441202)
30. Hintze JL (2000) NCSS 2000 Statistical System for Windows. User's Guide. Kaysville, UT: Number Cruncher Statistical Systems.
31. Horan WP, Kring AM, Blanchard JJ (2006) Anhedonia in schizophrenia: A review of assessment strategies. Schizophr Bull. 32:259-273.
32. Jerusalem M, Schwarzer R (1992) Self-efficacy as a resource factor in stress appraisal processes. In Schwarzer R (Ed), Self-efficacy: Thought control of action (pp 195-213). Washington, DC: Hemisphere.
33. Juckel G, Sass L, Heinz A (2003) Anhedonia, self-experience in schizophrenia, and implications for treatment. Pharmacopsychiatry. 36:S176-S180. (Pubitemid 38085134)
34. Katsanis J, Iacono WG, Beiser M, Lacey L (1992) Clinical correlates of anhedonia and perceptual aberration in first-episode patients with schizophrenia and affective disorder. J Abnorm Psychol. 101:184-191.
35. Kay SR, Fiszbein A, Opler LA (1987) The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 13:261-276. (Pubitemid 18039085)
36. Klein D (1987) Depression and anhedonia. In Clark DC, Fawcett J (Eds), Anhedonia and affect deficit states (pp 1Y34). New York: PMA Publishing.
37. Kollias CT, Kontaxakis VP, Havaki-Kontaxaki BJ, Stamouli S, Margariti M, Petridou E (2008) Association of physical and social anhedonia with depression in the acute phase of schizophrenia. Psychopathology. 41:365-370.
38. Kring AM, Moran EK (2008) Emotional response deficits in schizophrenia: Insights from affective science. Schizophr Bull. 34:819-834.
39. Kwapil TR (1998) Social anhedonia as a predictor of the development of schizophrenia-spectrum disorders. J Abnorm Psychol. 107:558-565. (Pubitemid 28527569)
40. La Guardia JG, Ryan RM, Couchman CE, Deci EL (2000) Within-person variation in security of attachment: A self-determination theory perspective on attachment, need fulfillment, and well-being. J Pers Soc Psychol. 79:367-384.
41. Lasalvia A, Ruggeri M, Santolini N (2002) Subjective quality of life: Its relationship with clinician-rated and patient-rated psychopathology. The South-Verona Outcome Project 6. Psychother Psychosom. 71:275-284. (Pubitemid 35007652)
42. Laurent A, Biloa-Tang M, Bougerol T, Duly D, Anchisi A-M, Bosson J-L, Pellat J, d'Amato T, Dalery J (2000) Executive/attentional performance and measures of schizotypy in patients with schizophrenia and in their nonpsychotic firstdegree relatives. Schizophr Res. 46:269-283.
43. Leak GK (1991) An examination of the construct validity of the Social Anhedonia Scale. J Pers Assess. 56:84-95.
44. Lehman AF (1988) A quality of life interview for the chronically mentally ill. Eval Program Plann. 11:51-62.
45. Leventhal AM, Chasson GS, Tapia E, Miller EK, Pettit JW (2006) Measuring hedonic capacity in depression: A psychometric analysis of three anhedonia scales. J Clin Psychol. 62:1545-1558. (Pubitemid 44862645)
46. Loas G, Boyer P, Legrand A (1999) Anhedonia in the deficit syndrome of schizo phrenia. Psychopathology. 32:207-219. (Pubitemid 29271916)
47. Loas G, Monestes JL, Ingelaere A, Noisette C, Herbener ES (2009) Stability and relationships between trait or state anhedonia and schizophrenic symptoms in schizophrenia: A 13-year follow-up study. Psychiatry Res. 66:132-140.
48. Loas G, Noisette C, Legrand A, Boyer P (2000) Is anhedonia a specific dimension in chronic schizophrenia? Schizophr Bull. 26:495-506. (Pubitemid 30423224)
49. Loas GP, Boyer P, Legrand A (1996) Anhedonia and negative symptomatology in chronic schizophrenia. Compr Psychiatry. 37:5Y11. (Pubitemid 26024870)
50. Maslow AH (1962) Toward a psychology of being. New York: Van Nostrand.
51. Meehl PE (1962) Schizotaxia, schizotypy, schizophrenia. Am Psychol. 17:827-838.
52. Miettunen J, Veijola J, Freimer N, Lichtermann D, Peltonen L, Paunio T, Isohanni M, Joukamaa M, Ekelunde J (2010) Data on schizotypy and affective scales are gender and education dependent. Study in the Northern Finland 1966 Birth Cohort. Psychiatry Res 178:408-413.
53. Ormel J, Oldehinkel AJ, Vollebergh W (2004) Vulnerability before, during, and after a major depressive episode: A 3-wave population-based study. Arch Gen Psychiatry. 61:990-996. (Pubitemid 39336532)
54. Orsel S, Akdemir A, Dag I (2004) The sensitivity of quality-of-life scale WHOQOL- 100 to psychopathological measures in schizophrenia. Compr Psychiatry. 45: 57-61. (Pubitemid 38029975)
55. Packer S, Husted J, Cohen S, Tomlinson G (1998) Psychopathology and quality of life in schizophrenia. J Psychiatry Neurosci. 22:231-234. (Pubitemid 127488586)
56. Paradiso S, Andreasen NC, Crespo-Facorro B, O'Leary DS, Watkins GL, Boles Ponto LL, Hichwa RD (2003) Emotions in unmedicated patients with schizophrenia during evaluation with positron emission tomography. Am J Psychiatry. 160:1775-1783. (Pubitemid 41103310)
57. Parker JD, Endler NS (1992) Coping with coping assessment: A critical review. Eur J Pers. 6:321-344.
58. Pelizza L, Ferrari A (2009) Anhedonia in schizophrenia and major depression: State or trait? Ann Gen Psychiatry. 8:22.
59. Peterson CA, Knudson RM (1983) Anhedonia: A construct validation approach. J Pers Assess. 47:539-551. (Pubitemid 14188388)
60. Phillips ML, Drevets WC, Rauch SL, Lane R (2003) Neurobiology of emotion perception I: The neural basis of normal emotion perception. Biol Psychiatry. 54:504-514. (Pubitemid 37289437)
61. Rado S (1962) Psychoanalysis of behaviour; collected papers 1956-1961 (Vol 2). New York: Grune and Stratton.
62. Rauch SL, Shin LM, Wright CI (2003) Neuroimaging studies of amygdala function in anxiety disorders. Ann N Y Acad Sci. 985:389-410. (Pubitemid 36521129)
63. Ritsner MS (2007) The Distress/Protection Vulnerability Model of the quality of life impairment syndrome: Current evidence and new directions for research. In Ritsner MS, Awad AG (Eds), Quality of life impairment in schizophrenia, mood and anxiety disorders. New perspectives on research and treatment (pp 3Y19). Dordrecth, the Netherlands: Springer.
64. Ritsner MS, Awad AG (Eds)(2007) Quality of life impairment in schizophrenia, mood and anxiety disorders. New perspectives on research and treatment. Dordrecth, the Netherlands: Springer; 388
65. Ritsner MS, Gibel A (2007) Quality of life impairment syndrome in schizophrenia. In Ritsner MS, Awad AG (Eds), Quality of life impairment in schizophrenia, mood and anxiety disorders. New perspectives on research and treatment (pp 173-226). Dordrecth, the Netherlands: Springer.
66. Ritsner M, Gibel A, Ratner Y (2006) Determinants of changes in perceived quality of life in the course of schizophrenia. Qual Life Res. 15:515-526.
67. Ritsner M, Kurs R, Gibel A, Hirschmann S, Shinkarenko E, Ratner Y (2003) Predictors of quality of life in major psychoses: A naturalistic follow-up study. J Clin Psychiatry. 64:308-315. (Pubitemid 36457329)
68. Ritsner M, Modai I, Endicott J, Rivkin O, Nechamkin Y, Barak P, Goldin V, Ponizovsky A (2000) Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients. J Clin Psychiatry. 61: 880-889.
69. Ritsner M, Modai I, Rivkin O, Bystrov E, Nehamkin Y, Ponizovsky A (1999) Distress scale for adverse symptoms: A new instrument for measuring the relationship between adverse drug symptoms and associated distress. 12th ECNP Congress 1999 London, United Kindgom, September 21-25, 1999. Eur Neuropsychopharmacol. 9:S258.
70. Ritsner M, Modai I, Ponizovsky A (2002b) Assessing psychological distress in psychiatric patients: Validation of the Talbieh Brief Distress Inventory. Compr Psychiatry. 43:229-234. (Pubitemid 34507473)
71. Ritsner M, Ponizovsky A, Endicott J, Nechamkin Y, Rauchverger B, Silver H, Modai I (2002a) The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: A naturalistic study. Eur Neuropsychopharmacol. 12:31-38. (Pubitemid 34098828)
72. Ritsner M, Rabinowitz J, SlyuzbergM (1995) The Talbieh Brief Distress Inventory: A brief instrument to measure psychological distress among immigrants. Compr Psychiatry. 36:448-453.
73. Ritsner M, Susser E (2004) Temperament types are associated with weak selfconstruct, elevated distress, and emotion-oriented coping in schizophrenia: Evidence for a complex vulnerability marker? Psychiatry Res. 128:219-228. (Pubitemid 39490841)
74. Roux P, Christophe A, Passerieux C (2010) The emotional paradox: Dissociation between explicit and implicit processing of emotional prosody in schizophrenia. Neuropsychologia. 48:3642-3649.
75. Ryan RM, Deci EL (2001) On happiness and human potentials: A review of research on hedonic and eudaimonic well-being. Annu Rev Psychol. 52: 141-166. (Pubitemid 33705570)
76. Shayegan DK, Stahl SM (2005) Emotion processing, the amygdala, and outcome in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 29:840-845. (Pubitemid 40897802)
77. Sullivan G, Wells KB, Leake B (1991) Quality of life of seriously mentally ill persons in Mississippi. Hosp Commun Psychiatry. 42:752-755.
78. Szoke A, Schurhoff F, Ferhadian N, Bellivier F, Rouillon F, Leboyer M (2002) Temperament in schizophrenia: A study of the tridimensional personality questionnaire (TPQ). Eur Psychiatry. 17:379-383. (Pubitemid 35429271)
79. Taylor SF, Phan KL, Britton JC, Liberzon I (2005) Neural response to emotional salience in schizophrenia. Neuropsychopharmacology. 30:984-995. (Pubitemid 40570913)
80. van Rijn S, Aleman A, Swaab H, Kahn RS (2005) Neurobiology of emotion and high risk for schizophrenia: Role of the amygdala and the X-chromosome. Neurosci Biobehav Rev. 29:385-397. (Pubitemid 40488205)
81. Velthorst E, Nieman DH, Becker HE, van de Fliert R, Dingemans PM, Klaassen R, de Haan L, van Amelsvoort T, Linszen DH (2009) Baseline differences in clinical symptomatology between ultrahigh risk subjects with and without a transition to psychosis. Schizophr Res. 109:60-65.
82. Voruganti LN, Heslegrave RJ, Awad AG (1997) Quality of life measurement during antipsychotic drug therapy of schizophrenia. J Psychiatry Neurosci. 22: 267-274. (Pubitemid 127488589)
83. White L, Harvey PD, Opler L, Lindenmayer JP (1997) Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group. Psychopathology. 30:263-274.
84. Wilson IB, Cleary PD (1995) Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA. 273:59-65.
85. Wise RA (2008) Dopamine and reward: The anhedonia hypothesis 30 years on. Neurotox Res. 14:169-183.
86. Wolf DH (2006) Anhedonia in schizophrenia. Curr Psychiatry Rep. 8:322-328. (Pubitemid 44227240)
87. Wolf JRLM (1997) Client needs and quality of life. Psychiatr Rehabil J. 20:16-24.
88. Young AS, Sullivan G, Burnam MA (1998) Measuring the quality of outpatient treatment for schizophrenia. Arch Gen Psychiatry. 28:1221-1230.
89. Zimet GD, Dahlem NW, Zimet SG, Farley GK (1988) The Multidimensional Scale of Perceived Social Support. J Pers Assess. 52:30-41.